Asset Management - Income
Compare Stocks
4 / 10Stock Comparison
NXN vs NXC vs BLK vs IVZ
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management - Income
Asset Management
Asset Management
NXN vs NXC vs BLK vs IVZ — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Asset Management - Income | Asset Management - Income | Asset Management | Asset Management |
| Market Cap | $48M | $86M | $165.65B | $11.92B |
| Revenue (TTM) | $2M | $4M | $20.41B | $6.38B |
| Net Income (TTM) | $3M | $7M | $6.10B | $-243M |
| Gross Margin | 100.0% | 100.0% | 49.4% | 43.2% |
| Operating Margin | 89.9% | 90.8% | 37.1% | -10.9% |
| Forward P/E | 30.4x | 38.0x | 20.1x | 10.4x |
| Total Debt | $0.00 | $6K | $14.22B | $10.12B |
| Cash & Equiv. | $685K | $391K | $12.76B | $1.98B |
NXN vs NXC vs BLK vs IVZ — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | Jan 26 | Return |
|---|---|---|---|
| Nuveen New York Sel… (NXN) | 100 | 92.9 | -7.1% |
| Nuveen California S… (NXC) | 100 | 85.8 | -14.2% |
| BlackRock, Inc. (BLK) | 100 | 202.5 | +102.5% |
| Invesco Ltd. (IVZ) | 100 | 329.6 | +229.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NXN vs NXC vs BLK vs IVZ
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NXN is the clearest fit if your priority is growth exposure.
- Rev growth 5.6%, EPS growth 140.4%
- 5.6% NII/revenue growth vs NXC's -28.6%
NXC carries the broadest edge in this set and is the clearest fit for sleep-well-at-night.
- Lower volatility, beta 0.04, Low D/E 0.0%, current ratio 4.13x
- Efficiency ratio 0.1% vs IVZ's 0.5% (lower = leaner)
- Beta 0.04 vs IVZ's 1.67, lower leverage
- Efficiency ratio 0.1% vs IVZ's 0.5%
BLK is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 15 yrs, beta 1.28, yield 1.9%
- 245.8% 10Y total return vs IVZ's 22.1%
- 1.9% yield, 15-year raise streak, vs IVZ's 3.1%, (2 stocks pay no dividend)
IVZ is the #2 pick in this set and the best alternative if defensive is your priority.
- Beta 1.67, yield 3.1%, current ratio 43.01x
- Lower P/E (10.4x vs 20.1x)
- +93.1% vs NXC's +4.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 5.6% NII/revenue growth vs NXC's -28.6% | |
| Value | Lower P/E (10.4x vs 20.1x) | |
| Quality / Margins | Efficiency ratio 0.1% vs IVZ's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.04 vs IVZ's 1.67, lower leverage | |
| Dividends | 1.9% yield, 15-year raise streak, vs IVZ's 3.1%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +93.1% vs NXC's +4.2% | |
| Efficiency (ROA) | Efficiency ratio 0.1% vs IVZ's 0.5% |
NXN vs NXC vs BLK vs IVZ — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
NXN vs NXC vs BLK vs IVZ — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
IVZ leads in 2 of 6 categories
BLK leads 1 • NXN leads 0 • NXC leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — NXN and NXC each lead in 2 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
BLK is the larger business by revenue, generating $20.4B annually — 9211.8x NXN's $2M. NXN is the more profitable business, keeping 71.7% of every revenue dollar as net income compared to IVZ's -4.4%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $2M | $4M | $20.4B | $6.4B |
| EBITDAEarnings before interest/tax | $271,884 | $7M | $8.3B | $1.2B |
| Net IncomeAfter-tax profit | $3M | $7M | $6.1B | -$243M |
| Free Cash FlowCash after capex | $0 | $0 | $3.9B | $1.9B |
| Gross MarginGross profit ÷ Revenue | +100.0% | +100.0% | +49.4% | +43.2% |
| Operating MarginEBIT ÷ Revenue | +89.9% | +90.8% | +37.1% | -10.9% |
| Net MarginNet income ÷ Revenue | +71.7% | +60.7% | +31.2% | -4.4% |
| FCF MarginFCF ÷ Revenue | — | — | +23.0% | +22.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | — | -88.4% | -22.7% | +34.2% |
Valuation Metrics
IVZ leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 25.4x trailing earnings, BLK trades at a 33% valuation discount to NXC's 38.0x P/E. On an enterprise value basis, IVZ's 16.3x EV/EBITDA is more attractive than BLK's 20.6x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $48M | $86M | $165.7B | $11.9B |
| Enterprise ValueMkt cap + debt − cash | $47M | $85M | $167.1B | $20.1B |
| Trailing P/EPrice ÷ TTM EPS | 30.35x | 37.97x | 25.42x | -16.77x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 20.10x | 10.44x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 3.13x | — |
| EV / EBITDAEnterprise value multiple | — | — | 20.62x | 16.34x |
| Price / SalesMarket cap ÷ Revenue | 21.51x | 23.16x | 8.12x | 1.87x |
| Price / BookPrice ÷ Book value/share | 0.96x | 0.96x | 3.28x | 0.94x |
| Price / FCFMarket cap ÷ FCF | — | — | 35.24x | 8.27x |
Profitability & Efficiency
BLK leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
BLK delivers a 9.9% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $-2 for IVZ. NXC carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to IVZ's 0.78x. On the Piotroski fundamental quality scale (0–9), BLK scores 6/9 vs NXC's 3/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +5.1% | +8.3% | +9.9% | -1.7% |
| ROA (TTM)Return on assets | +5.1% | +8.3% | +3.7% | -0.9% |
| ROICReturn on invested capital | +3.0% | +2.8% | +9.9% | -2.3% |
| ROCEReturn on capital employed | +4.0% | +3.8% | +5.8% | -2.6% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 3 | 6 | 6 |
| Debt / EquityFinancial leverage | — | 0.00x | 0.29x | 0.78x |
| Net DebtTotal debt minus cash | -$685,136 | -$390,878 | $1.5B | $8.1B |
| Cash & Equiv.Liquid assets | $685,136 | $390,878 | $12.8B | $2.0B |
| Total DebtShort + long-term debt | $0 | $6,477 | $14.2B | $10.1B |
| Interest CoverageEBIT ÷ Interest expense | 962.63x | 85.16x | 9.27x | -6.19x |
Total Returns (Dividends Reinvested)
IVZ leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BLK five years ago would be worth $13,352 today (with dividends reinvested), compared to $9,665 for NXC. Over the past 12 months, IVZ leads with a +93.1% total return vs NXC's +4.2%. The 3-year compound annual growth rate (CAGR) favors IVZ at 21.6% vs NXC's 3.1% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +1.0% | +1.2% | -1.1% | +0.4% |
| 1-Year ReturnPast 12 months | +8.3% | +4.2% | +18.3% | +93.1% |
| 3-Year ReturnCumulative with dividends | +11.5% | +9.7% | +75.7% | +79.8% |
| 5-Year ReturnCumulative with dividends | +0.9% | -3.4% | +33.5% | +8.2% |
| 10-Year ReturnCumulative with dividends | +17.5% | +13.1% | +245.8% | +22.1% |
| CAGR (3Y)Annualised 3-year return | +3.7% | +3.1% | +20.7% | +21.6% |
Risk & Volatility
Evenly matched — NXN and NXC each lead in 1 of 2 comparable metrics.
Risk & Volatility
NXC is the less volatile stock with a 0.04 beta — it tends to amplify market swings less than IVZ's 1.67 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NXN currently trades 98.9% from its 52-week high vs BLK's 87.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.05x | 0.04x | 1.28x | 1.67x |
| 52-Week HighHighest price in past year | $12.28 | $13.45 | $1219.94 | $29.61 |
| 52-Week LowLowest price in past year | $11.24 | $12.66 | $914.84 | $14.10 |
| % of 52W HighCurrent price vs 52-week peak | +98.9% | +98.8% | +87.5% | +90.6% |
| RSI (14)Momentum oscillator 0–100 | 55.0 | 60.1 | 61.3 | 69.4 |
| Avg Volume (50D)Average daily shares traded | 0 | 0 | 790K | 5.1M |
Analyst Outlook
Evenly matched — BLK and IVZ each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: BLK as "Buy", IVZ as "Hold". Consensus price targets imply 22.8% upside for BLK (target: $1312) vs 10.8% for IVZ (target: $30). For income investors, IVZ offers the higher dividend yield at 3.10% vs BLK's 1.92%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Buy | Hold |
| Price TargetConsensus 12-month target | — | — | $1311.78 | $29.72 |
| # AnalystsCovering analysts | — | — | 33 | 28 |
| Dividend YieldAnnual dividend ÷ price | — | — | +1.9% | +3.1% |
| Dividend StreakConsecutive years of raises | — | — | 15 | 4 |
| Dividend / ShareAnnual DPS | — | — | $20.46 | $0.83 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +1.2% | +15.6% |
IVZ leads in 2 of 6 categories (Valuation Metrics, Total Returns). BLK leads in 1 (Profitability & Efficiency). 3 tied.
NXN vs NXC vs BLK vs IVZ: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NXN or NXC or BLK or IVZ a better buy right now?
For growth investors, Nuveen New York Select Tax-Free Income Portfolio (NXN) is the stronger pick with 555.
5% revenue growth year-over-year, versus -28. 6% for Nuveen California Select Tax-Free Income Portfolio (NXC). BlackRock, Inc. (BLK) offers the better valuation at 25. 4x trailing P/E (20. 1x forward), making it the more compelling value choice. Analysts rate BlackRock, Inc. (BLK) a "Buy" — based on 33 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NXN or NXC or BLK or IVZ?
On trailing P/E, BlackRock, Inc.
(BLK) is the cheapest at 25. 4x versus Nuveen California Select Tax-Free Income Portfolio at 38. 0x. On forward P/E, Invesco Ltd. is actually cheaper at 10. 4x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — NXN or NXC or BLK or IVZ?
Over the past 5 years, BlackRock, Inc.
(BLK) delivered a total return of +33. 5%, compared to -3. 4% for Nuveen California Select Tax-Free Income Portfolio (NXC). Over 10 years, the gap is even starker: BLK returned +245. 8% versus NXC's +13. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NXN or NXC or BLK or IVZ?
By beta (market sensitivity over 5 years), Nuveen California Select Tax-Free Income Portfolio (NXC) is the lower-risk stock at 0.
04β versus Invesco Ltd. 's 1. 67β — meaning IVZ is approximately 4086% more volatile than NXC relative to the S&P 500. On balance sheet safety, Nuveen California Select Tax-Free Income Portfolio (NXC) carries a lower debt/equity ratio of 0% versus 78% for Invesco Ltd. — giving it more financial flexibility in a downturn.
05Which is growing faster — NXN or NXC or BLK or IVZ?
By revenue growth (latest reported year), Nuveen New York Select Tax-Free Income Portfolio (NXN) is pulling ahead at 555.
5% versus -28. 6% for Nuveen California Select Tax-Free Income Portfolio (NXC). On earnings-per-share growth, the picture is similar: Nuveen New York Select Tax-Free Income Portfolio grew EPS 140. 4% year-over-year, compared to -235. 6% for Invesco Ltd.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NXN or NXC or BLK or IVZ?
Nuveen New York Select Tax-Free Income Portfolio (NXN) is the more profitable company, earning 71.
7% net margin versus -4. 4% for Invesco Ltd. — meaning it keeps 71. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NXC leads at 90. 8% versus -10. 9% for IVZ. At the gross margin level — before operating expenses — NXN leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NXN or NXC or BLK or IVZ more undervalued right now?
On forward earnings alone, Invesco Ltd.
(IVZ) trades at 10. 4x forward P/E versus 20. 1x for BlackRock, Inc. — 9. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BLK: 22. 8% to $1311. 78.
08Which pays a better dividend — NXN or NXC or BLK or IVZ?
In this comparison, IVZ (3.
1% yield), BLK (1. 9% yield) pay a dividend. NXN, NXC do not pay a meaningful dividend and should not be held primarily for income.
09Is NXN or NXC or BLK or IVZ better for a retirement portfolio?
For long-horizon retirement investors, Nuveen California Select Tax-Free Income Portfolio (NXC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
04)). Invesco Ltd. (IVZ) carries a higher beta of 1. 67 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (NXC: +13. 1%, IVZ: +22. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NXN and NXC and BLK and IVZ?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: NXN is a small-cap high-growth stock; NXC is a small-cap quality compounder stock; BLK is a mid-cap quality compounder stock; IVZ is a mid-cap income-oriented stock. BLK, IVZ pay a dividend while NXN, NXC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.